Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 9 Breast Neoplasms 7 Obesity 4 Colorectal Neoplasms 4 Rectal Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sarcoma 2 Radiation Injuries 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Weight Loss 1 Uterine Cervical Dysplasia 1 Stage IV Breast Cancer AJCC v6 and v7 1 Sezary Syndrome 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Prostate Adenocarcinoma 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Patient Compliance 1 Overweight 1 Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1

Interventions

Exercise 4 Counseling 3 Nutrition Assessment 2 Naltrexone 2 Metformin 2 Exenatide 2 Diet 2 Cognitive Behavioral Therapy 2 Caloric Restriction 2 Bupropion 2 sultamicillin 1 licogliflozin 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Tobacco Use Cessation Devices 1 Surveys and Questionnaires 1 Sugars 1 Sucrose 1 Standard of Care 1 Resistance Training 1 Psychology, Positive 1 Propofol 1 Motivational Interviewing 1 Mindfulness-Based Stress Reduction 1 Methods 1 Flutamide 1 Ethinyl Estradiol 1 Diet, Mediterranean 1 Diet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Overweight × Diet Therapy × Clear all

NCT03489213 2019-08-30

NExT

Ohio State University Comprehensive Cancer Center

Phase NA Completed

Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡